Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-04
DOI
10.1186/s12933-022-01697-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study
- (2022) Min Wu et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex
- (2022) Yasuhiro Matsubayashi et al. Cardiovascular Diabetology
- MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups
- (2022) Hyoeun Kim et al. DIGESTIVE DISEASES AND SCIENCES
- Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
- (2022) Jingxuan Quek et al. Endocrine Practice
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- The transition from NAFLD to MAFLD: One size still does not fit all—Time for a tailored approach?
- (2022) Laurens A. Kleef et al. HEPATOLOGY
- Effects of Experimental Sleep Restriction on Energy Intake, Energy Expenditure, and Visceral Obesity
- (2022) Naima Covassin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
- (2022) Javier Delgado-Lista et al. LANCET
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
- (2022) Naveed Sattar et al. NATURE MEDICINE
- SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
- (2022) Jun Sung Moon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Tirzepatide adds hepatoprotection to its armoury
- (2022) Giovanni Targher Lancet Diabetes & Endocrinology
- The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome
- (2022) Takumi Noda et al. Journal of Clinical Medicine
- Letter to the editor: Is NAFLD a bystander or contributor to coronary artery disease?
- (2022) Ziyu Xun et al. HEPATOLOGY
- A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population
- (2022) Ya-Cong Zhang et al. Hepatology International
- Promoting the term MAFLD: China in action
- (2022) Xin-Lei Zhang et al. Lancet Gastroenterology & Hepatology
- Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
- (2022) Alessandro Mantovani et al. GUT
- Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
- (2021) Anat Yaskolka Meir et al. GUT
- Management of non-alcoholic fatty liver disease
- (2021) Maria Letizia Petroni et al. BMJ-British Medical Journal
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- MAFLD and cardiovascular events: what does the evidence show?
- (2021) Jacob George et al. Clinical Gastroenterology and Hepatology
- Treatments for NAFLD: State of Art
- (2021) Alessandro Mantovani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
- (2021) Madunil Anuk Niriella et al. PLoS One
- Role of Insulin Resistance in MAFLD
- (2021) Yoshitaka Sakurai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
- (2021) Hao-Jie Zhang et al. CHINESE MEDICAL JOURNAL
- MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
- (2021) Tsubasa Tsutsumi et al. HEPATOLOGY RESEARCH
- Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China
- (2021) Yebei Liang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
- (2021) Nobuharu Tamaki et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
- (2021) Donghee Kim et al. JOURNAL OF HEPATOLOGY
- The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
- (2021) Shanshan Liu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- PPAR control of metabolism and cardiovascular functions
- (2021) David Montaigne et al. Nature Reviews Cardiology
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
- (2021) Qi Huang et al. Frontiers in Medicine
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
- (2021) Vy H. Nguyen et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
- (2021) Giulio Marchesini et al. DIGESTIVE AND LIVER DISEASE
- Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
- (2021) Seogsong Jeong et al. Gut and Liver
- Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
- (2021) Joon Ho Moon et al. Gut and Liver
- Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
- (2021) Hui-Hui Liu et al. Hepatology International
- Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
- (2021) Masato Yoneda et al. JOURNAL OF GASTROENTEROLOGY
- Diabetes and metabolic dysfunction-associated fatty liver disease
- (2021) Timothy M.E. Davis METABOLISM-CLINICAL AND EXPERIMENTAL
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis
- (2021) Xiao-Jing Zhang et al. Science Translational Medicine
- A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques
- (2021) Xiao-Jing Zhang et al. Science Translational Medicine
- Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future
- (2021) Ting-Yao Wang et al. Hepatobiliary Surgery and Nutrition
- Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
- (2021) Kaneez Fatima et al. Clinics and Research in Hepatology and Gastroenterology
- Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
- (2020) Jingjing Cai et al. CIRCULATION RESEARCH
- Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease
- (2020) Mateus Dornelles Severo Clinical Gastroenterology and Hepatology
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
- (2020) Eugene Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
- (2020) Ze Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
- (2020) Sven Francque et al. Nature Reviews Gastroenterology & Hepatology
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- Clinical utility of the MAFLD definition
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- The NAFLD‐MAFLD debate: Eminence vs evidence
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2020) Alessandro Mantovani et al. Metabolites
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genetic Inhibition of PCSK9 and Liver Function
- (2020) Antoine Rimbert et al. JAMA Cardiology
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- The Beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content
- (2019) Yftach Gepner et al. JOURNAL OF HEPATOLOGY
- The association between liver fat and systemic calcified atherosclerosis
- (2019) Bo Kyung Koo et al. JOURNAL OF VASCULAR SURGERY
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
- (2019) Stanley Khoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
- (2019) Yan Liu et al. Scientific Reports
- Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study
- (2019) Kuan Ken Lee et al. Lancet Gastroenterology & Hepatology
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials
- (2019) Iram Amanullah et al. POSTGRADUATE MEDICAL JOURNAL
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- (2019) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
- (2019) Francesco Baratta et al. Clinical Gastroenterology and Hepatology
- Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone
- (2018) Lawrence H. Young et al. CIRCULATION
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
- (2018) Maria Angela Incalza et al. VASCULAR PHARMACOLOGY
- Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial
- (2018) Paola Portillo-Sanchez et al. Journal of Diabetes
- The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
- (2018) Javier Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
- (2018) Omar A Mesarwi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors
- (2018) Eleni Theocharidou et al. CURRENT PHARMACEUTICAL DESIGN
- PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease
- (2017) Nynke Simons et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression
- (2016) Lorenzo A. Orci et al. Clinical Gastroenterology and Hepatology
- Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
- (2016) Kathleen E. Corey et al. DIGESTIVE DISEASES AND SCIENCES
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
- (2016) Kunihiro Nishimura et al. Journal of Atherosclerosis and Thrombosis
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and Incident Cardiac Events
- (2016) Irfan Zeb et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes: A Systematic Review and Meta‐Analysis
- (2016) Ahad Wahid et al. Journal of the American Heart Association
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies
- (2015) Wenjuan Tang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
- (2015) Ken Sato et al. NUTRITION
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis
- (2014) AhmedA. Sarkhy et al. Saudi Journal of Gastroenterology
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Methods of accelerated atherosclerosis in diabetic patients
- (2013) Gerard Pasterkamp HEART
- Dose Response Between Physical Activity and Risk of Coronary Heart Disease
- (2011) Jacob Sattelmair et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now